Summary
Glycosylation of low density lipoproteins obtained from 16 patients with Type 1 (insulin-dependent) diabetes and from 16 age-, sex-, and race-matched controls, was determined. The diabetic patients were normolipaemic and were in good or fair glycaemic control. Eleven patients performed home blood glucose monitoring. Glycosylation of low density lipoproteins in the diabetic patients was significantly higher (p < 0.001) than in the control subjects, and was significantly correlated with haemoglobin A1c, (p < 0.01), glycosylation of plasma proteins, (p < 0.001), and mean home blood glucose, (p < 0.01). This study confirms that, in diabetic patients, increased glycosylation of low density lipoprotein occurs to an extent which correlates closely with other commonly used indices of glycaemic control.
Article PDF
Similar content being viewed by others
References
Nomenclature Committee of IUB, Joint Commission on Biochemical Nomenclature (1984) Newsletter Biochem J 217: I-IV
Kennedy L, Baynes JW (1984) Nonenzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia 26:93–98
Entmacher PS, Krall LP, Kranczer SN (1985) Diabetes mortality from vital statistics. In: Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS (eds) Joslin's diabetes mellitus, 12th edn. Lea and Febiger, Philadelphia, pp 278–297
Gonen B, Baenziger J, Schonfeld G, Jacobson D, Farrar P (1981) Nonenzymatic glycosylation of low density lipoproteins in vitro. Diabetes 30: 875–878
Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D (1982) Nonenzymatic glucosylation of low density lipoprotein alters its biologic activity. Diabetes 31: 283–291
Steinbrecher UP, Witztum JL (1984) Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33: 130–134
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Havel RJ, Eden HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
Lowry OH, Rosebrough NJ, Farr AL, Randall BJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Yue DK, McLennan S, Turtle JR (1981) Non-enzymatic glycosylation of tissue protein in diabetes in the rat. Diabetologia 24: 377–381
Baynes JW, Thorpe SR, Murtiashaw MH (1984) Nonenzymatic glucosylation of lysine residues in albumin. Methods Enzymol 106:88–98
Fields R (1971) The measurement of amino groups in proteins and peptides. Biochem J 124: 581–590
Snyder SL, Sobocinski PZ (1975) An improved 2,4,6-Trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem 64:284–288
Kadish AH, Little RL, Steinberg JC (1968) A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116–131
Spicer KN, Allen RC, Buse MG (1978) A simplified assay of hemoglobin A1c in diabetic patients, using isoelectric focusing and quantitative microdensitometry. Diabetes 27: 384–388
Department of Health, Education and Welfare (1974) Manual of lipid operations. Lipid Research Clinics Program, Vol 1. Lipid and lipoprotein analysis, NHLI, NIH, Bethesda, Maryland, Publ No (NIH) 75–628
Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield RK, Sagel J, Leroy EC, Colwell JA (1982) Surface binding, internalization and degradation by cultured human fibroblasts of low-density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 22: 430–436
Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 23: 882–884
Zar JH (1984) Biostatistical analysis. Prentice-Hall Inc., Englewood Cliffs, NJ
Schleicher E, Deufel T, Wieland OH (1981) Non-enzymatic glycosylation of human serum lipoproteins. FEBS Lett 129: 1–4
Curtiss LK, Witztum JL (1985) Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 34: 452–461
Gitlin D, Cornwell DG, Nakasato D, Oncley JL, Hughes WL, Jr, Janeway CA (1958) Studies on the metabolism of plasma proteins in the nephrotic syndrome. (II. The lipoproteins). J Clin Invest 37: 172–184
Schultze HE, Heremans JF (1966) Molecular biology of human proteins, Vol 1. Elsevier, Amsterdam, p 476
Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL (1986) Metabolism of in vitro glucosylated LDL (Glu-LDL) by human monocyte-derived macrophages. Diabetes 35 (Suppl 1): 89A
Lyons TJ, Klein RL, Baynes JW, Lopes-Virella MF (1986) Stimulation of cholesteryl ester (CE) synthesis in human monocyte-derived macrophages by LDL isolated from diabetic patients. Clin Res 34: 208a
Garcia MJ, McNamara PM, Gordon T, Kannell WB (1974) Morbidity and mortality in diabetics in the Framingham population. Diabetes 23: 105–111
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham Study. JAMA 241: 2035–2038
Jarrett RJ, McCartney P, Keen H (1982) The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22: 79–84
Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary heart disease risk and impaired glucose tolerance — The Whitehall Study. Lancet 1: 1373–1376
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lyons, T.J., Baynes, J.W., Patrick, J.S. et al. Glycosylation of low density lipoprotein in patients with Type I (insulin-dependent) diabetes: Correlations with other parameters of glycaemic control. Diabetologia 29, 685–689 (1986). https://doi.org/10.1007/BF00870276
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00870276